T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Price:
5 870 ILS
0.95%
Market Closed
Updated:
May 11, 2024
Teva Pharmaceutical Industries Ltd
Other Operating Expenses
|
Teva Pharmaceutical Industries Ltd
Other Operating Expenses Peer Comparison
Comparables:
TARO
I
INCR
MDWD
R
REKA
C
CSURE
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Other Operating Expenses
$15m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Other Operating Expenses
-₪4m
|
CAGR 3-Years
58%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Other Operating Expenses
$211k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Other Operating Expenses
-₪2.7m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Other Operating Expenses
-₪80k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Teva Pharmaceutical Industries Ltd's Other Operating Expenses?
Other Operating Expenses
15m
USD
15m
USD
Based on the financial report for Dec 31, 2023, Teva Pharmaceutical Industries Ltd's Other Operating Expenses amounts to 15m USD.
What is Teva Pharmaceutical Industries Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
-45%
-45%
Over the last year, the Other Operating Expenses growth was -50%. The average annual Other Operating Expenses growth rates for Teva Pharmaceutical Industries Ltd have been -9% over the past three years , -45% over the past five years .
You don't have any saved screeners yet
